Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$27.44 - $35.56 $219,959 - $285,048
8,016 New
8,016 $235,000
Q4 2019

Feb 11, 2020

SELL
$39.01 - $47.51 $215,725 - $262,730
-5,530 Closed
0 $0
Q3 2019

Oct 17, 2019

BUY
$38.66 - $47.41 $29,265 - $35,889
757 Added 15.86%
5,530 $253,000
Q2 2019

Aug 02, 2019

BUY
$38.23 - $47.43 $182,471 - $226,383
4,773 New
4,773 $206,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.